CR
CXT
ATEC
XGN

James L. L. Tullis

Known title: 10% OwnerCIK: 0001230641

James L. L. Tullis's purchase track record

James L. L. Tullis has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
6/15/2023XGN$519-26.4%-50.9%
6/15/2022ATEC$51K+31.1%+54.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

No Material News for CR in the Past Week. Crane Company did not have any company‑specific news releases or earnings updates in the last seven days. The stock remains in a neutral technical environment, with RSI near 58 and support at $206.30. Analysts maintain a target of $237.20, but no new catalysts have emerged.

this person other insiders at CR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

Crane NXT Appoints New Director, Sets Q3 Earnings Date. Crane NXT has appointed Jeong H. Kim to its board of directors and announced the date for its third-quarter 2026 earnings release. These corporate updates provide clarity on leadership and upcoming financial reporting for the industrial company.

this person other insiders at CXT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Alphatec Appoints Tommy Carls as EVP for Data Intelligence. Alphatec Holdings has named Tommy Carls as Executive Vice President of Data Intelligence and Strategy. This leadership addition focuses on the company's data capabilities and strategic direction. The stock is currently trading within its 52-week range, with analyst targets averaging $15.79.

this person other insiders at ATEC

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

TD Cowen Raises Exagen Price Target to $11. TD Cowen has maintained its positive stance on Exagen, raising its price target to $11. This update aligns with the broader analyst consensus, where the average target sits at $10.14. The move provides context for the stock's current position within its 52-week range of $2.59 to $12.23.

this person other insiders at XGN

Transaction History

CR▼ Sell$82K
CR▼ Sell$138K
CR▲ Buy$0
CXT▲ Buy$0
CXT▼ Sell$0
CR▼ Sell$0
CXT▼ Sell$0
CXT▼ Sell$0
ATEC▼ Sell$516K
ATEC▼ Sell$1.0M
CXT▼ Sell$0
ATEC▲ Buy$0
XGN▲ Buy$519
CR▼ Sell$0
ATEC▲ Buy$22K
ATEC▲ Buy$517K
ATEC▲ Buy$376K
ATEC▼ Sell$21K
ATEC▼ Sell$517K
ATEC▼ Sell$376K
ATEC▲ Buy$22K
ATEC▲ Buy$517K
ATEC▲ Buy$376K
ATEC▼ Sell$21K
ATEC▼ Sell$517K
ATEC▼ Sell$376K
ATEC▼ Sell$484K
ATEC▼ Sell$530K
ATEC▲ Buy$0
ATEC▲ Buy$51K
ATEC▼ Sell$0
ATEC▼ Sell$0
ATEC▼ Sell$21K
ATEC▼ Sell$370K
ATEC▼ Sell$509K
ATEC▼ Sell$509K
ATEC▼ Sell$370K
ATEC▼ Sell$21K
ATEC▼ Sell$641K
ATEC▼ Sell$236K
CXT▲ Buy$94K
CXT▼ Sell$209K
CXT▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.